Prostate Services and Procedures and Impotence Treatment
Medicare Advantage policy describing Medicare-related coverage guidance, references, and applicable procedure/HCPCS/CPT codes for prostate-related interventions (temporary prostatic stents, prostatic urethral lift, nerve graft during radical prostatectomy, prostate artery embolization, HIFU/cryoablation) and impotence-related prosthetics/devices. It primarily references Commercial Medical Policies and Medicare NCDs/LCDs and provides coding lists and usage instructions.
Coverage Rationale: removed content/language addressing prostate rectal spacers.
Prostatic Urethral Lift (PUL) heading modified and language revised to note Medicare does not have an NCD and LCDs/LCAs do not exist; refers to UnitedHealthcare Commercial Medical Policy.
Prostate Artery Embolization (PAE) section added language regarding complications from long-term untreated BPH, including acute urinary retention and kidney injury.
Replaced prior language to state simply that Medicare has a general NCD for Therapeutic Embolization (NCD 20.28).
Removed CPT code 55874 from Applicable Codes list.
Updated CMS Related Documents list to reflect current information; removed Clinical Evidence and FDA sections.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.